13,246
Total Claims
$1.3M
Drug Cost
1,036
Beneficiaries
$1,249
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-18%
Cost per patient vs peers
$1,249 vs $1,524 avg
-22%
Brand preference vs peers
10.7% vs 13.7% avg
Opioid Prescribing
0.1%
Opioid Rate
17
Opioid Claims
$78
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
89% generic
Brand: 1,413 claims · $1.0M
Generic: 11,833 claims · $275K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 654 | $522K |
| Sacubitril/Valsartan | 125 | $118K |
| Ticagrelor | 148 | $101K |
| Rivaroxaban | 98 | $70K |
| Dapagliflozin Propanediol | 80 | $69K |
| Ranolazine | 557 | $56K |
| Empagliflozin | 52 | $49K |
| Metoprolol Succinate | 966 | $16K |
| Isosorbide Mononitrate | 688 | $15K |
| Atorvastatin Calcium | 1,117 | $14K |
| Droxidopa | 16 | $12K |
| Evolocumab | 15 | $10K |
| Clopidogrel Bisulfate | 696 | $8,876 |
| Potassium Chloride | 523 | $7,944 |
| Dabigatran Etexilate Mesylate | 22 | $7,425 |
Prescribing Profile
88
Unique Drugs
$829K
Patient Profile
71
Avg Age
57%
Female
1.83
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data